Generic Paxil Flap Ends Without Explanation

By Jessica Corso (December 23, 2015, 7:54 PM EST) -- Litigation over generic Paxil sales ended Tuesday, when the embroiled drugmakers quietly agreed to drop the New Jersey federal suit accusing GlaxoSmithKline LLC of breaching an exclusivity agreement with Mylan by allowing Apotex to sell generics of the antidepressant in resolving an antitrust dispute....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!